2012•The Chinese Journal of Clinical PharmacologyRequires access

Antibacterial activity of mupirocin against multi-resistance Staphylococcus aureus in vitro

Yun Li

Open publisher page 0 citations

Abstract

Objective To evaluate the in vitro antibacterial activity of mupirocin and other compounds against clinical isolated Staphylococcus aureus.Method A total of 1007 pathogenic isolates 23 tertiary hospitals from 2007 to 2010 in China were studied.The MICs were determined by the twofold agar dilution method.Results Mupirocin exhibited excellent antibacterial activity against Staphylococcus aureus.The values of MIC50 and MIC90 were 0.25,0.50 mg·L-1,respectively.Mupirocin resistance rates against Staphylococcus aureus and methicillin-resistance Staphylococcus aureus(MRSA) were 0.6% and 0.9%,which were the lowest among tested agents.Against triple antibiotic ointment or fusidic acid-resistance trains,mupirocin susceptible rates were about 80%.Mupirocin resistance rates against Staphylococcus aureus isolated from various specimen types were between 0-1.0%,secretion isolated strains' resistance was 0.Conclusion Mupirocin resistance rate against MRSA was lower than other tested topical agents.And show good antibacterial activity against MRSA and other resistance strains.There was no cross-resistance between mupirocin and clinically available antibiotics.

About this research paper

What this paper is about

Objective To evaluate the in vitro antibacterial activity of mupirocin and other compounds against clinical isolated Staphylococcus aureus.Method A total of 1007 pathogenic isolates 23 tertiary hospitals from 2007 to 2010 in China were studied.The MICs were determined by the twofold agar dilution method.Results Mupirocin exhibited excellent antibacterial activity against Staphylococcus aureus.The values of MIC50 and MIC90 were 0.25,0.50 mg·L-1,respectively.Mupirocin resistance rates against Staphylococcus aureus and methicillin-resistance Staphylococcus aureus(MRSA) were 0.6% and 0.9%,which were the lowest among tested agents.Against triple antibiotic ointment or fusidic acid-resistance trains,mupirocin susceptible rates were about 80%.Mupirocin resistance rates against Staphylococcus aureus isolated from various specimen types were between 0-1.0%,secretion isolated strains' resistance was 0.Conclusion Mupirocin resistance rate against MRSA was lower than other tested topical agents.And show good antibacterial activity against MRSA and other resistance strains.There was no cross-resistance between mupirocin and clinically available antibiotics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the in vitro antibacterial activity of mupirocin and other compounds against clinical isolated Staphylococcus aureus.Method A total of 1007 pathogenic isolates 23 tertiary hospitals from 2007 to 2010 in China were studied.The MICs were determined by the twofold agar dilution method.Results Mupirocin exhibited excellent antibacterial activity against Staphylococcus aureus.The values of MIC50 and MIC90 were 0.25,0.50 mg·L-1,respectively.Mupirocin resistance rates against Staphylococcus aureus and methicillin-resistance Staphylococcus aureus(MRSA) were 0.6% and 0.9%,which were the lowest among tested agents.Against triple antibiotic ointment or fusidic acid-resistance trains,mupirocin susceptible rates were about 80%.Mupirocin resistance rates against Staphylococcus aureus isolated from various specimen types were between 0-1.0%,secretion isolated strains' resistance was 0.Conclusion Mupirocin resistance rate against MRSA was lower than other tested topical agents.And show good antibacterial activity against MRSA and other resistance strains.There was no cross-resistance between mupirocin and clinically available antibiotics.

Key concepts: Mupirocin, Staphylococcus aureus, Microbiology, Fusidic acid, Medicine, Methicillin-resistant Staphylococcus aureus, Agar Dilution Method, Antibiotics

Related papers

Back to paper searchBrowse research topicsOriginal source
Antibacterial activity of mupirocin against multi-resistance Staphylococcus aureus in vitro — Research Paper | ScholarLens